Grifols, S.A(NASDAQ:GRFS) 
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others segments. The Bioscience segment produces plasma-derived medicines for the treatment...
Website: http://www.grifols.com
Founded: 1940
Full Time Employees: 24,000
Sector: Healthcare
Industry: Drug Manufacturers-General
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 6.94
H 7.06
L 6.57
C 6.65
V 1,029,658
10EMA 6.65
20EMA 6.65
60EMA 6.65
120EMA 6.65
250EMA 6.65